Jamie Cleckler
Podiatrist · Birmingham, ALNPI 1174562755
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by Stryker at 46.2% of the total. 2025 is the largest year on record at $1,184, 2.0 times the $592 reported in 2019.
Across 157 payments — averaging $28.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Amgen$356
- Smith+Nephew$267
- AbbVie$258
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$242
- Musculoskeletal Transplant Foundation Inc.$181
- plus $1K from 25 others
What the payments were for
- Food & beverage$4,537100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 48 | $2,097 |
| Amgen(2 entities) | 16 | $356 |
| Smith+Nephew | 6 | $267 |
| AbbVie | 15 | $258 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 14 | $242 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $181 |
| Paratek Pharmaceuticals, Inc. | 9 | $142 |
| Osiris Therapeutics Inc. | 2 | $131 |
| Paragon 28, Inc. | 1 | $112 |
| Melinta Therapeutics, LLC | 5 | $92 |
| Kerecis Limited | 4 | $82 |
| Globus Medical | 2 | $62 |
| Kowa Pharmaceuticals America, Inc. | 4 | $55 |
| Boston Scientific | 3 | $53 |
| Johnson & Johnson | 2 | $52 |
| Bioventus LLC | 2 | $39 |
| Merck | 3 | $39 |
| Zyla Life Sciences, Inc. | 3 | $39 |
| Abbott | 2 | $29 |
| Vertex | 1 | $23 |
| GRT US Holding, Inc. | 1 | $21 |
| Solventum Corporation | 1 | $21 |
| Mimedx Group, Inc. | 1 | $20 |
| Orthofix Medical, Inc. | 1 | $20 |
| Heron Therapeutics, Inc. | 1 | $19 |
| Medtronic | 1 | $19 |
| Integra Lifesciences Corporation | 1 | $14 |
| ERMI LLC | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $13 |
| DJO, LLC | 1 | $13 |
| Metric Medical Devices, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stravix$240
- Grafix$240
- ORTHOLOC 2 LAPIFUSE$171
- SONICANCHOR$123
- Grafix XC$122
- GRAFIX PL$122
- GrafixPL$118
- ASNIS$117
- Grappler$112
- AUGMENT INJECTABLE$111
How this compares
$4,537 in reported general payments places this provider in the 80th percentile of 59 podiatrist providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 89 | $4,675 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 98 | $2,334 |
| Ketoconazole | 57 | $1,738 |
| Mupirocin | 152 | $1,362 |
| Terbinafine Hcl | 111 | $1,284 |
| Ammonium Lactate | 47 | $928 |
| Cephalexin | 47 | $751 |
| SsdSilver Sulfadiazine | 62 | $552 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 11 | $543 |
| Clindamycin Hcl | 30 | $441 |
| Diclofenac Sodium | 61 | $438 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 58 | $412 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 53 | $357 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $332 |
| Levofloxacin | 51 | $268 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Birmingham
- John RobersonBirmingham$10K
- Kyle MaukBirmingham$10K
- Brent HaverstockBirmingham$7K
- David LindeBirmingham$6K
- Maurice WainwrightBirmingham$2K
- John CalcateraBirmingham$1K
- Rupa JayagopalBirmingham$972
- Kevin WaldropBirmingham$556
- Mark GotfrydBirmingham$428
- Mark KunkelBirmingham$111
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.